Skip to main content
BMC Public Health logoLink to BMC Public Health
. 2025 Jul 15;25:2465. doi: 10.1186/s12889-025-23692-2

Retrospective review of deaths in the Massachusetts department of corrections after passage of medical parole

Jasdeep S Kler 1, Amanda Victory 1, Samantha Chao 2,✉, Michelle Suh 3, Nicole Mushero 4
PMCID: PMC12261610  PMID: 40665310

Abstract

Background

There are roughly 6,000 individuals incarcerated in the Massachusetts Department of Corrections (MADOC), and in 2025, 32% of these individuals were age 50 and older. Older incarcerated individuals have a higher burden of chronic disease, and caring for them is associated with higher healthcare costs. In 2018, Massachusetts passed legislation enabling medical parole, a process by which an individual can be released due to terminal illness or permanent incapacitation. Existing literature suggests medical parole is underutilized. The aim of this study was to characterize the cause of death of individuals in MADOC custody to determine potential medical parole eligibility and gaps in referrals.

Methods

We conducted a retrospective analysis of deaths of individuals in MADOC custody between 2021 and 2023 using death records obtained from MADOC and death certificates from the Massachusetts Vital Statistics Program. Cause of death was categorized through structured review of death certificates and supplemental MADOC medical documentation.

Results

Between January 1, 2021 and December 31, 2023, 87 individuals died in MADOC custody. The primary disease processes leading to death involved infection (28%), complications of chronic disease (25%), and cancer (22%). Nearly half (41.7%) of infection-related deaths were due to COVID-19. The most common causes of death categorized by primary organ system were cardiovascular conditions (26%) and respiratory conditions (25%). The majority of deaths were attributed to acute causes (58%).

Conclusions

In our study, nearly half of the population died in custody from a chronic condition or complications related to a chronic condition and could have been identified for medical parole eligibility. The majority of individuals died from acute causes, suggesting the need for an expedited review process and expanded eligibility criteria. A small number of correctional facilities and hospitals saw the majority of deaths, and these locations may be ideal targets for future interventions. Further work is needed to compare death data before and after the COVID-19 pandemic, assess barriers to utilization of medical parole, and explore other interventions to decrease the number of deaths in MADOC custody.

Keywords: Incarcerated, Prisons, Medical parole, Compassionate release, Terminal illness

Background

There are approximately 1.2 million people incarcerated in the United States prison system with roughly 6,000 of those in the Massachusetts Department of Corrections (MADOC) [1, 2]. As the U.S. prison population continues to age, at an even more rapid rate than the general population, correctional facilities will face increasing healthcare demands. Currently, the Federal Bureau of Prisons reports that 20% of inmates in the U.S. are age 51 and older [3]. By comparison, 32% of those incarcerated in the MADOC in 2025 are age 50 and older [4]. Older incarcerated individuals have more chronic diseases, mental health conditions, and mobility issues compared to their younger counterparts [5], and caring for this population inevitably involves higher healthcare costs. Many individuals die while still incarcerated: those who are terminally ill have variable access to palliative and end-of-life services and have experiences fraught with mistrust of the prison system [6, 7].

Medical parole, or compassionate release, has been proposed as a mechanism to address the rapidly aging population and their increased health needs [8, 9]. Medical parole refers to the release of an incarcerated individual based on a terminal illness or permanent incapacitation. Professional organizations, including the American Medical Association and National Commission on Correctional Health Care, encourage clinicians to advocate for the compassionate release of patients particularly out of an ethical obligation to promote dignity and appropriate care at the end of life [10, 11]. Medical parole can be valuable as it allows unrestricted visitation by family, hospice services, and removal of shackles. In 2018, Massachusetts was one of the last states to pass medical parole legislation [12]. Eligible individuals must have a “debilitating condition that appears incurable, that will likely cause the death of the inmate in not more than eighteen (18) months or a debilitating physical or cognitive incapacitation that appears irreversible as determined by the Department’s medical provider” [G.L. c. 127 § 119 A]. Petitions for medical parole may be submitted by the incarcerated individual or someone on their behalf and can take up to three months from the time of submission until a decision is rendered.

In fiscal year 2020, less than 10% of applicants were granted medical parole in Massachusetts [12], and the process is still fraught with issues, including cases reported by local news outlets of parole eligibility being revoked in the setting of improving health and individuals dying in custody after being granted medical parole [13, 14]. This data mirrors national trends of underutilization of medical parole despite widespread legislation [13–16]. Potential explanations for this underutilization include inadequate identification of eligible candidates or fundamental issues with the eligibility criteria themselves [17].

In this study, we reviewed death certificates of those who died in MADOC custody between 2021 and 2023, after passage of the Massachusetts medical parole legislation. We sought to evaluate the specified causes of death and determine whether deaths resulted from known chronic conditions, terminal illnesses, or occurred more unexpectedly. Characterizing the causes of death of individuals in MADOC custody may illuminate if and how many individuals with chronic or terminal diseases may have been identified for medical parole eligibility or if individuals died from other causes that do not meet the current legal definitions of terminal illness and permanent incapacitation. Of note, the years of the study period coincide with the height of the COVID-19 pandemic, which may have increased both absolute death counts and acute causes of death compared to non-pandemic years. However, pandemic conditions heighten both the need for and calls to expand medical parole making lessons from this period broadly applicable [18]. No studies to date have examined MADOC deaths in custody after implementation of the 2018 medical parole legislation. Identifying potential gaps in medical parole referrals remains crucial for improving the system’s effectiveness.

Methods

Study sample

We conducted a retrospective analysis of deaths among individuals incarcerated in MADOC from January 1, 2021 to December 31, 2023. This timeframe was selected for several reasons. Although medical parole legislation was passed in 2018, there were few medical parole applications in 2018 and 2019 due to decreased awareness of and unfamiliarity with the legislation. We excluded 2020 from our analysis following consultation with advocacy lawyers experienced in medical parole cases who noted that limited COVID-19 testing availability in MADOC facilities during the early pandemic significantly affected illness classification and death reporting accuracy [19]. The study period ended with 2023 because 2024 data remained incomplete when this analysis began.

Inclusion criteria were all decedents under MADOC supervision. Data on deaths were requested from MADOC by a local nonprofit legal services organization via the Massachusetts Public Records Law. A listing of the incarcerated people who died in the custody of DOC (Department of Corrections) during the study period was requested, whether they died at the prison or at an outside hospital, with the following information: name, date of death, cause of death, place of death, whether the death was a suicide or homicide, and whether the death was expected or not expected. MADOC provided the information requested with no further negotiation required. Race/ethnicity and sex were also provided, and individuals are asked to self-report race/ethnicity on entry to MADOC. Death events and detailed cause-of-death information was linked to the Massachusetts Vital Statistics Program (MVSP) using multiple identifiers, including name, year of birth, and date of death. One decedent did not have a matching death certificate in the MVSP dataset. In this case, a team member requested access to a copy of the death certificate from the City of Boston website. This research project was deemed exempt by the Boston University Institutional Review Board as the subjects were no longer living and all death-related data is publicly available.

Cause of death classification

Cause of death was determined through structured review of death certificates and MADOC medical documentation. Two members of the study team (JK and AV) assigned each cause of death a primary organ system involved (e.g., cardiovascular, respiratory, renal, etc.) and disease process (e.g. cancer, hemorrhage, infection, suicide, etc.). Two other members of the study team (SC and MS) assigned disease onset (acute versus chronic) for each case’s cause of death. Cohen’s Kappa was used to assess interrater reliability with a value of 0.98 (weighted) for organ system coding, 0.97 (unweighted) for disease process coding, and 0.93 (unweighted) for disease onset coding. Disagreements were resolved through consensus discussion.

Covariates and outcomes

Our primary outcome of interest was cause of death, which was coded to include variables for natural vs. unnatural (including suicides, homicides, and trauma) cause of death, primary organ system(s) involved, primary disease process involved, and whether the condition was acute or chronic. Secondary outcomes included the facility with custody of the decedent at time of death and the place of death. We also analyzed demographic factors including age at death, race/ethnicity, and sex.

Data analysis

Descriptive statistics were used to summarize demographics, cause of death, and prison custody date. We calculated frequencies and proportions for categorical variables and mean/medians for continuous variables. Statistical analyses were conducted with SAS 9.4 (Cary, NC).

Results

Between January 1, 2021 and December 31, 2023, a total of 87 individuals died while in the custody of MADOC. This represents approximately 1.4% of the individuals in MADOC custody in December 2023. The average age at death was 64.1 years (median 66, SD = 11.0) with decedents ranging in age from 35 to 88 years. The majority were identified as male (97%) with three deaths (3%) occurring among individuals identified as female. The majority of decedents identified as White and non-Hispanic (71%, n = 62). 17% identified as Black and non-Hispanic (n = 15), 8% as Hispanic (n = 7), 2.3% as American Indian or Alaska Native (n = 2), and 1.2% as Asian or Pacific Islander (n = 1). There were more deaths in 2021 (n = 38) compared to 2022 (n = 28) and 2023 (n = 21) (Table 1).

Table 1.

Demographics of individuals who died in Massachusetts Department of Corrections custody from 2021–2023

n %
Total decedents 87
Year of death
2021 38 43.7
2022 28 32.2
2023 21 24.1
Sex
Female 3 3.4
Male 84 96.6
Race/Ethnicity
White Non-Hispanic 62 71.3
Black Non-Hispanic 15 17.2
Hispanic 7 8.0
American Indian/Alaska Native 2 2.3
Asian/Pacific Islander Non-Hispanic 1 1.2

Table 1 describes the year of death, sex, and race/ethnicity of individuals who died in Massachusetts Department of Corrections custody between the years 2021 and 2023 represented as n (the absolute number of individuals) and as a percentage of total decedents in the sample

Most individual deaths were recorded as natural (92%, n = 80) with only seven deaths (8%) ruled as unnatural. The most common primary disease process leading to death involved infection (28%, n = 24) followed by complications of chronic disease (25%, n = 22) and cancer (22%, n = 19). Ten decedents’ primary cause of death involved COVID-19 (11.5%), and all but one of these COVID-related deaths occurred in 2021. The remaining infection-related deaths were attributed to unspecified pneumonia (9%, n = 8), sepsis (5%, n = 4), urinary tract infection (2%, n = 2), and bacteremia (1%, n = 1); often, these processes were co-occurring. In terms of primary organ systems responsible for death, cardiovascular conditions were the most frequently identified (26%) followed closely by respiratory conditions (25%). Other systems involved included gastrointestinal (9%), hematologic (7%), renal (7%), hepatic (6%), nervous system (3%), and a small number involving multiple organ systems. Eight cases (9%) were not associated with a primary organ system and included causes of death involving suicide, homicide, or overdose. The majority of deaths were due to acute causes (58%, n = 50) (Table 2).

Table 2.

Causes of death of individuals in Massachusetts Department of Corrections custody from 2021–2023

n %
Total decedents 87
Cause of death
Natural 80 91.9
Unnatural 7 8.0
Place of death
Hospital (Inpatient) 61 70.1
Hospital (Outpatient/ED) 16 18.4
Dead on Arrival 8 9.2
Other 2 2.3
Organ system
Cardiovascular 23 26.4
Respiratory 22 25.3
Gastrointestinal 8 9.2
Renal 6 6.9
Hematological 6 6.9
Hepatic 5 5.7
Nervous System 3 3.4
Genitourinary 2 2.3
Head and Neck 1 1.1
Soft Tissue 1 1.1
Multiple Organ System 2 2.3
Other 8 9.2
Disease onset
Acute 50 57.5
Chronic 37 42.5
Primary disease process
Aortic Dissection 1 1.1
Arrhythmia 3 3.4
Bowel Perforation; Infection 1 1.1
Cancer 18 20.7
Cardiac Arrest 1 1.1
Colonic Obstruction 1 1.1
Complication of Chronic Disease; Cancer 1 1.1
Complication of Chronic Disease 21 24.1
COPD Exacerbation 1 1.1
Gastrointestinal Hemorrhage 2 2.3
Hyperviscosity Syndrome 1 1.1
Infection 23 26.4
Intracranial Hemorrhage 2 2.3
Overdose 3 3.4
Pancreatitis 1 1.1
Suicide/Homicide 4 4.6
Trauma 2 2.3
Venous Thromboembolism 1 1.1

Table 2 describes the cause of death of individuals in Massachusetts Department of Corrections custody between 2021 and 2023 represented as n (the absolute number of individuals) and as a percentage of total decedents in the sample. It lists whether the death was due to natural causes or unnatural causes, where individuals died (place of death), the primary organ system involved in the disease process listed as the proximate cause of death, whether the proximate cause of death was an acute or chronic process, and the primary disease process specified as causing death

Most deaths occurred in inpatient hospital settings (70%, n = 61) while 18% (n = 16) occurred in the emergency department or outpatient settings. Only 9% (n = 8) were categorized as “dead on arrival,” and 2.3% (n = 2) occurred in other locations (Table 2). Among the 20 listed hospitals on death certificates represented in the sample, four hospitals were listed on over half of the death certificates (58%, n = 50), including a correctional hospital managed by MADOC. Similarly, although there are 13 MADOC facilities in our sample, five facilities had custody of more than 75% of our sample (n = 66).

Discussion

Although the overall prison population in Massachusetts is small, it has one of the oldest populations in the country and can serve as an example of the ways death may manifest among older incarcerated people [20]. There were 87 deaths in MADOC custody between 2021 and 2023. Based on the most recent data published by the Bureau of Justice, the mortality rate in state prisons was 330 per 100,000 state prisoners in 2019 [21]. From 2019 to 2023, the age-adjusted death rate in Massachusetts was 703.6 per 100,000 compared to 805.6 per 100,000 nationally [22].

We found the most common cause of death of those in MADOC custody was infection followed by complications related to chronic disease. Nearly half of infection-related deaths were attributed to COVID-19 with the remaining deaths being attributed to unspecified pneumonia, sepsis, bacteremia, and urinary tract infections. In 2021, the COVID mortality rate in Massachusetts was 54.6 per 100,000 total population [23]. Based on this study’s data and the average MADOC population in 2021 [24], the COVID mortality rate of those in MADOC custody was nearly three times as high at an estimated 144 per 100,000. This reflects known disparities in COVID-related deaths between those who are incarcerated and the general population [19]. Cardiovascular conditions were the most common cause of death when categorized by organ system. These trends are consistent with Massachusetts state data as infectious disease and heart disease were the leading causes of death for residents from 2021 to 2022 [25, 26]. Almost all deaths were of natural causes. The average age of our sample was significantly older than the average person under MADOC supervision (64 compared to 44) [27]. Most deaths in custody occurred in the inpatient setting.

In this study, 43% of individuals who died between 2021 and 2023 had chronic conditions documented prior to their death and could have been identified for the medical parole process. The remaining majority of decedents in our study died of an acute illness, and 70% died in an inpatient setting. Individuals who died in these contexts would not have easily applied for medical parole in Massachusetts in the process’ current form. Those with severe acute illness undergoing active hospitalization would likely not survive the three-month wait for a decision to be rendered let alone the additional time it may take to be released after parole approval [28]. Furthermore, one could imagine being denied medical parole on the basis that an acute illness such as an infection is neither permanently incapacitating nor incurable. If a motivation for compassionate release legislation is to avoid deaths in custody and provide dignified end-of-life care, those who die from an acute or unexpected illness deserve attention. This gap could be addressed by improving the efficiency of the current parole review process, developing a separate expedited application process, or potentially expanding current criteria for medical parole eligibility. Additionally, as patients in the acute dying process may not have the ability to advocate for themselves, it may be beneficial for the MADOC to conduct regularly scheduled and urgent reviews of incarcerated individuals’ medical records to identify eligible individuals. Further work is needed to elucidate whether individuals who died in custody had medical parole petitions submitted or pending at the time of death.

In our sample, a small number of correctional facilities and hospitals saw the majority of deaths. These institutions may be valuable pilot sites for future interventions given the increased number of eligible applicants receiving care there. For community health providers, interventions could include education on the medical parole process and how to recognize people who may be eligible for medical parole when they come to the hospital. Interventions in the MADOC could include assessing provider and staff awareness of eligibility criteria as well as current barriers to initiating applications from within the correctional system. Pilot programs demonstrating collaboration between DOCs and referral hospitals have shown success in improving the medical parole process in other states [29].

There were several limitations of this study. The study period encompassed the peak of the COVID-19 pandemic, which likely impacted the number of acute deaths and infection-related deaths. As data surrounding medical parole applications in Massachusetts continues to be collected, further work can compare death data to trends pre- and post-COVID. Another limitation included the constraints of pre-collected data. The study population was primarily male as only one of the 13 currently open MADOC facilities is dedicated to individuals designated female, and we were unable to clearly identify individuals in our sample who may have been transgender. As with all studies relying on death certificate documentation, we were limited by the narrow scope of information provided, missing information, errors, and variability in certificate completion. For example, multiple disease processes, both acute and chronic, were often listed as the cause of death. Significant interpretation was required during the coding process, and distinguishing between acute and chronic causes of death was at times challenging. Deaths attributed to acute causes may have had chronic conditions that were not specified on the death certificate, leading to an underestimate of who may have been identified as eligible for medical parole based on a chronic condition. Concerns have also been raised about the lack of peer review and quality assurance of death documentation within corrections and when deaths involve law enforcement [30]. Given significant variation among states regarding their medical parole criteria, processes, and correctional systems, the generalizability of our study is also limited.

Our study was exploratory in nature, thus future work is needed to assess barriers to a successful petition for medical parole, including the reasons why a medical parole petition may be denied. Pinpointing unmet criteria—or lack thereof—would provide insight into how the definitions of terminal illness and permanent incapacitation could be expanded upon to increase approval rates and best accommodate the medical needs of chronically and acutely ill incarcerated individuals.

Conclusion

Further research is needed to identify and address barriers to seeking and achieving medical parole. To our knowledge, this study is the first to explore deaths of individuals in MADOC custody. Our data suggests nearly half of those who died in MADOC custody between 2021 and 2023 could have been identified for medical parole eligibility based on existing chronic diseases. The majority of decedents died of acute illness further suggesting a need for a more expedited process and potential expanded eligibility criteria. The continued aging of this population will only increase the need for a structured, efficient process to address the health needs for incarcerated individuals.

Acknowledgements

The authors would like to acknowledge Prisoners’ Legal Services of Massachusetts for their expertise and support in this work.

Abbreviations

DOC

Department of Corrections

MADOC

Massachusetts Department of Correction

MVSP

Massachusetts Vital Statistics Program

Authors’ contributions

NM, SC, and MS designed study and obtained records. JK and AV coded the primary organ system involved and disease process. SC and MS coded the disease onset. SC and MS analyzed the medical parole applications. JK performed all other analyses and prepared Tables 1 and 2. JK, AV, and SC were major contributors to the manuscript. All authors read, revised, and approved the final manuscript.

Funding

Nicole Mushero received funding from the Health Resources and Services Administration (HRSA) to support this work, grant number K0149060. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. Nicole Mushero is also the recipient of a Boston University School of Medicine Department of Medicine Career Investment Award.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No datasets were generated or analysed during the current study.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES